Loading company
$4.56+15.2%Nov 12 close
Figures through June 30, 2026, from the 6-K filed September 30, 2026
Past performance
- 1W
- +14.9%
- 1M
- +10.4%
- 3M
- +38.3%
- 6M
- +8.6%
- 1Y
- -76.9%
- 5Y
- -97.9%
$4.56+15.2%Nov 12 close
Figures through June 30, 2026, from the 6-K filed September 30, 2026
The quarter ending March 30, 2026, against the same quarter a year earlier.
| Measure | 3 months toMar 30, 2026 | 3 months toMar 31, 2025 | Change |
|---|---|---|---|
| Total Revenue | $73K | $2.1M | -96.45% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
CollPlant Biotechnologies Ltd has no earnings call transcript available.
CollPlant Biotechnologies Ltd. (NASDAQ: CLGN) is an innovative technology company operating at the intersection of deep-tech computing and advanced biotechnology. Through its subsidiary LightSolver, CollPlant is advancing the development of proprietary all-optical laser based computing architectures designed to resolve the world’s most demanding computational bottlenecks across artificial intelligence, aerospace, financial engineering, and high-performance computing. Concurrently, CollPlant remains a leader in regenerative medicine, pioneering plant-derived recombinant human collagen (rhCollagen) technologies for 3D bioprinting of tissues and organs and medical aesthetics.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from the 6-K CollPlant Biotechnologies Ltd filed on September 30, 2026 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.